4.6 Review

Inflammatory effects of nutritional stimuli: further support for the need for a big picture approach to tackling obesity and chronic disease

Journal

OBESITY REVIEWS
Volume 11, Issue 2, Pages 137-149

Publisher

WILEY
DOI: 10.1111/j.1467-789X.2009.00644.x

Keywords

Environment; inflammation; nutrition; obesity

Ask authors/readers for more resources

The discovery of a form of low-grade systemic inflammation (called 'metaflammation'), and the close evolutionary link between the immune and metabolic systems, poses questions about the supposed antigens (inducers) of such an immune reaction. Initially, this was thought to be mediated through obesity. However, we have identified a number of lifestyle or environmentally related inducers that may cause metaflammation, even in the absence of obesity. In this paper, the third of a series linking obesity with broad environmental and evolutionary factors, we identify nutritional stimuli with evidence of an involvement in metaflammation. From this we propose that components of certain foods and beverages with which humans have not evolved, are more often the inducers of an inflammatory effect in the body than those with which humans have become more familiar, and to which a neutral, or anti-inflammatory response may be expected to have developed. The implications of such a finding are considered in relation to broader aspects of the environment, economic growth, policy change and current global financial issues.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Surgery

Bariatric-Metabolic Surgery Utilisation in Patients With and Without Diabetes: Data from the IFSO Global Registry 2015-2018

Richard Welbourn, Marianne Hollyman, Robin Kinsman, John Dixon, Ricardo Cohen, John Morton, Amir Ghaferi, Kelvin Higa, Johan Ottosson, Francois Pattou, Salman Al-Sabah, Merhan Anvari, Jacques Himpens, Ronald Liem, Villy Vage, Peter Walton, Wendy Brown, Lilian Kow

Summary: International comparative practice of bariatric-metabolic surgeries for T2DM patients is not well understood. Older men with higher rates of BMI <35 kg/m2 have an increased likelihood of having T2DM and undergoing food rerouting operations.

OBESITY SURGERY (2021)

Article Anesthesiology

Epidemiology of Trauma History and Body Pain: A Retrospective Study of Community-Based Australian Women

Alison Flehr, Jan Coles, John B. Dixon, Stephen J. Gibson, Samuel L. Brilleman, Melissa L. Harris, Deborah Loxton

Summary: The relationship between interpersonal injury and body pain was found to be mediated by biopsychological burden, while the relationship between physical injury and body pain was not. Patients with a history of interpersonal injury and body pain were found to have a greater biopsychological burden.

PAIN MEDICINE (2021)

Article Medicine, General & Internal

Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants

Nicholas L. Syn, David E. Cummings, Louis Z. Wang, Daryl J. Lin, Joseph J. Zhao, Marie Loh, Zong Jie Koh, Claire Alexandra Chew, Ying Ern Loo, Bee Choo Tai, Guowei Kim, Jimmy Bok-Yan So, Lee M. Kaplan, John B. Dixon, Asim Shabbir

Summary: Metabolic-bariatric surgery significantly reduces all-cause mortality and extends life expectancy in obese adults, with a more pronounced effect seen in patients with pre-existing diabetes.

LANCET (2021)

Article Peripheral Vascular Disease

MicroRNA-132 may be associated with blood pressure and liver steatosis-preliminary observations in obese individuals

Nina Eikelis, John B. Dixon, Elisabeth A. Lambert, Geula Hanin, Yonat Tzur, David S. Greenberg, Hermona Soreq, Francine Z. Marques, Michael T. Fahey, Geoffrey A. Head, Markus P. Schlaich, Gavin W. Lambert

Summary: The study revealed an association between miR-132 and markers of cardiovascular and metabolic disease, suggesting that reduction of miR-132 may be a target for regulating liver lipid homeostasis and controlling obesity-related blood pressure.

JOURNAL OF HUMAN HYPERTENSION (2022)

Article Gastroenterology & Hepatology

Unhealthy Eating, Psychopathology, and Nonalcoholic Fatty Liver Disease in Youth Presenting for Bariatric Surgery

Sanita L. Ley, Meg H. Zeller, Jennifer Reiter-Purtill, David E. Kleiner, John Dixon, Stavra Xanthakos

Summary: This study found that certain unhealthy eating behaviors are associated with the occurrence of pediatric nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), and internalizing psychopathology is also associated with an increased risk of NAFLD.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2021)

Article Endocrinology & Metabolism

Outcomes of the first global multidisciplinary consensus meeting including persons living with obesity to standardize patient-reported outcome measurement in obesity treatment research

Claire E. E. de Vries, Caroline B. Terwee, May Al Nawas, Bart A. van Wagensveld, Ignace M. C. Janssen, Ronald S. L. Liem, Simon W. Nienhuijs, Ricardo Cohen, Elisabeth F. C. van Rossum, Wendy A. Brown, Amir A. Ghaferi, Johan Ottosson, Karen D. Coulman, Tarissa B. Z. Petry, Stephanie Sogg, Lisa West-Smith, Jason C. G. Halford, Ximena Ramos Salas, John B. Dixon, Salman Al-Sabah, Wei-Jei Lee, John Roger Andersen, Stuart W. Flint, Maarten M. Hoogbergen, Brooke Backman, Ellen Govers, Nadya Isack, Caroline Clay, Susie Birney, Maureen Gunn, Paul Masterson, Audrey Roberts, Jacky Nesbitt, Riccardo Meloni, Sarah le Brocq, Sandra de Blaeij, Christina Kraaijveld, Floor van der Steen, Bibian Visser, Petra Hamers, Valerie M. Monpellier

Summary: The lack of standardization in measuring patient-reported outcomes (PROs) and PRO measures (PROMs) has led to the quality of life being underrepresented in obesity treatment research. The S.Q.O.T. initiative aims to standardize the measurement of quality of life in obesity treatment, and the first consensus meeting brought together experts and patients to identify key PROs and preferred PROMs. This meeting provided a first step towards standardizing PROs and PROMs in obesity treatment research.

OBESITY REVIEWS (2022)

Editorial Material Dermatology

Multicentre Selective Lymphadenectomy Trial 1: key primary data remain unavailable

Anthony Dixon, Athanassios Kyrgidis, Christopher Zachary, John Dixon, Catalin Popescu, Michael Sladden, Zoe Apalla, Stuart Anderson, Giuseppe Argenziano, Demitrios Ioannides, Alexander Nirenberg, Aimillios Lallas, Samuel Zagarella, Caterina Longo, Harvey Smith, Howard Steinman, Thrasivoulos Tzellos, Lloyd Cleaver, Ken Leahey, Christos C. Zouboulis, J. Meirion Thomas

BRITISH JOURNAL OF DERMATOLOGY (2022)

Article Endocrinology & Metabolism

The Australian Obesity Management Algorithm: A simple tool to guide the management of obesity in primary care

Tania P. Markovic, Joseph Proietto, John B. Dixon, Georgia Rigas, Gary Deed, Jeffrey M. Hamdorf, Erica Bessell, Nathalie Kizirian, Sofianos Andrikopoulos, Stephen Colagiuri

Summary: Obesity is a complex chronic disease with various factors, and it is associated with multiple complications. The treatment for non-pregnant adults with obesity should be determined based on their body indices (body mass index (BMI) and waist circumference) and the presence and severity of obesity-related complications. Supervised lifestyle interventions, such as reduced or low energy diet, very low energy diet (VLED), or pharmacotherapy, should be the focus for individuals with BMI 30-40 kg/m2 or abdominal obesity without complications, aiming for a weight loss of 10-15%. For individuals with BMI 30-40 kg/m2 or abdominal obesity and complications, or those with BMI > 40 kg/m2, a weight loss target of 10-15% body weight is recommended, and more intensive interventions like VLED, pharmacotherapy, or bariatric surgery may be required, potentially in combination. Those with BMI > 40 kg/m2 and complications should aim for a weight loss target of > 15% and be referred to specialist care, which may involve VLED with or without pharmacotherapy and bariatric surgery.

OBESITY RESEARCH & CLINICAL PRACTICE (2022)

Article Clinical Neurology

Effects of wearing textured versus smooth shoe insoles for 12 weeks on gait, foot sensation and patient-reported outcomes, in people with multiple sclerosis: a randomised controlled trial

Anna L. L. Hatton, Katrina Williams, Mark D. D. Chatfield, Sheree Hurn, Jayishni N. N. Maharaj, Elise M. M. Gane, Thomas Cattagni, John Dixon, Keith Rome, Graham Kerr, Sandra G. G. Brauer

Summary: Innovative shoe insoles designed to enhance sensory information on the plantar surface of the feet could improve walking in people with Multiple Sclerosis. However, a study comparing the effects of textured and smooth insoles found no differences in gait, foot sensation, and patient-reported outcomes. Further investigation is needed to explore optimal insole design.

BRAIN IMPAIRMENT (2023)

Article Psychology, Clinical

Mental health and quality of life during weight loss in females with clinically severe obesity: a randomized clinical trial

Daniel J. van den Hoek, Clint T. Miller, Steve F. Fraser, Steve E. Selig, Toni Rice, Mariee Grima, Carolina Ika Sari, Gavin W. Lambert, John B. Dixon

Summary: This study explored the effects of dietary weight loss intervention, with and without exercise, on health-related quality of life, depressive symptoms, and anxiety in premenopausal women. The results showed that the addition of exercise to energy restriction had a significant positive impact on health-related quality of life, depressive symptoms, and state and trait anxiety scores. Exercise can improve mental health and quality of life in women with severe obesity without further weight loss.

JOURNAL OF BEHAVIORAL MEDICINE (2023)

Letter Dermatology

Improved methodology in determining melanoma mortality and selecting patients for immunotherapy

A. J. Dixon, H. K. Steinman, A. Kyrgidis, H. Smith, M. Sladden, C. Zouboulis, G. Argenziano, Z. Apalla, A. Lallas, C. Longo, A. Nirenberg, C. Popescu, J. B. Dixon, T. Tzellos, C. Zachary, L. Cleaver, S. Anderson, S. Zagarella, J. M. Thomas

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Letter Surgery

Does a Measure for Weight Regain Provide a Useful Metric?

John B. Dixon

OBESITY SURGERY (2023)

Article Surgery

Development of a Bariatric Surgery Core Data Set for an International Registry

Karen D. D. Coulman, Katy Chalmers, Jane Blazeby, John Dixon, Lilian Kow, Ronald Liem, Dimitri J. J. Pournaras, Johan Ottosson, Richard Welbourn, Wendy Brown, Kerry Avery

Summary: This study developed a Core Registry Set (CRS) - core data to include in bariatric surgery registries globally, which is the first step towards unifying bariatric surgery registries internationally. We recommend the CRS is included as a minimum dataset in all bariatric registries worldwide. Adoption of the CRS will enable meaningful international comparisons of bariatric operations.

OBESITY SURGERY (2023)

Meeting Abstract Endocrinology & Metabolism

Pregnancy following Metabolic and Bariatric Surgery in Teens: Multicenter Prospective Cohort Study

Shelley Ehrlich, Jane Khoury, Anita Courcoulas, John Dixon, Michael Helmrath, Mary Evans, Kate McCracken, Eliza Buyers, Stephanie Sisley, Carroll Harmon, Marc Michalsky, Todd Jenkins, Thomas Inge

OBESITY (2021)

No Data Available